Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
MSD
Posted inNew Drugs, Oncology, Regulatory
Tivdak: New Drug for Cervical Cancer
Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Posted inOncology, Research
Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Welireg: New Treatment for Tumors in Von Hippel–Lindau Disease
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.
Posted inNeuroscience, New Drugs, Regulatory
Lyfnua: First Drug for Refractory or Unexplained Chronic Cough
Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.
Posted inNeuroscience, New Drugs, Regulatory
Quviviq: New Sleeping Pill
Daridorexant will help treat insomnia.
Posted inInfections, New Drugs, Regulatory
Livtencity: New Drug Against Post-Transplant Cytomegalovirus Infection
Maribavir will suppress cytomegalovirus when ganciclovir, valganciclovir, cidofovir, or foscarnet do not work.